Filana Therapeutics (FLNA) Research & Development (2010 - 2026)
Filana Therapeutics' Research & Development came in at $3.3 million for Q2 2026, down 35.4% from $5.12 million a year earlier and down 27.3% from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Filana Therapeutics reported Research & Development of $15.66 million, down 72.5% year-over-year; for FY2025, it came in at $26.59 million, down 61.8% from FY2024.
- Research & Development carries a four-year compound annual growth rate of 1.7% (FY2021 to FY2025).
- Going back by year, Research & Development was $69.64 million in FY2024 (-22.1%), $89.42 million in FY2023 (+31.4%), $68.03 million in FY2022 (+174.2%) and $24.81 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q2 2019.
- Year-over-year, Research & Development has declined for six consecutive quarters, with an average decline of 44.8% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2023 (growth of 27.4%), and the weakest in Q4 2025 (a decline of 81.2%).
- Business Quant data shows FLNA's Research & Development at $4.54 million (Q1 2026), $3.85 million (Q4 2025) and $3.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Filana Therapeutics | 32.11 Mn | -338.73 Mn | - | 3.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.30 Mn |
| Mar 31, 2026 | 4.54 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Sep 30, 2025 | 3.96 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | 13.67 Mn |
| Dec 31, 2024 | 20.53 Mn |
| Sep 30, 2024 | 17.68 Mn |
| Jun 30, 2024 | 15.20 Mn |
| Mar 31, 2024 | 16.23 Mn |
| Dec 31, 2023 | 18.73 Mn |
| Sep 30, 2023 | 23.60 Mn |
| Jun 30, 2023 | 24.97 Mn |
| Mar 31, 2023 | 22.12 Mn |
| Dec 31, 2022 | 17.65 Mn |
| Sep 30, 2022 | 18.53 Mn |
| Jun 30, 2019 | 308,000.00 |
| Mar 31, 2019 | 574,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 1.46 Mn |
API Access
Filana Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();